Liz Pingpank | Associate Director, Corporate Communications |
Nick Leschly | Chief Executive Officer |
Mohammed Asmal | Vice President, Clinical Development |
Philip Gregory | Chief Scientific Officer |
Salveen Richter | Goldman Sachs |
Schimmer | Evercore ISI |
Eric Schmidt | Cowen & Company |
Cory Kasimov | JP Morgan |
Jim Birchenough | Wells Fargo |
Matthew Harrison | Morgan Stanley |
Dane Leone | BTIG |
Michael Schmidt | Leerink Partners |
David Nierengarten | Wedbush Securities |
Matthew Luchini | BMO Capital |
Ying Huang | Bank of America |
Vincent Chen | Bernstein |
Biren Amin | Jefferies |
Huidong Wang | Barclays |
Good day, ladies and gentlemen, and welcome to the bluebird quarterly update and ASH 2017 Abstract Call. [Operator Instructions] I’d now like to introduce your host for today’s conference, Ms. Liz Pingpank. Ma’am, you may begin.
Thank you, operator, and good morning, everyone.